The Academy by Psych Scene

75% of anti-NMDA receptor encephalitis cases first present to psychiatrists, not neurologists.

Could a manic or psychotic episode be an immune-mediated brain attack?

Here’s what psychiatrists need to know about identifying and managing neuroinflammation.

Want to dive deeper into this case + learn how to detect and treat neuroimmune causes of psychiatric illness?

Explore the full article, “Anti-N-methyl-D-aspartate (Anti-NMDA) Receptor Encephalitis – A Synopsis” on The Psych Scene Hub.

Link in the comment section.

Skip the Carousel

1 2 3 4 5 6 7 8 9 10

22 hours ago | [YT] | 3

The Academy by Psych Scene

Addiction is not the problem.

It’s the solution the brain found.

To manage it, we must first understand:

"What was it trying to solve?"

To go deeper into addiction neurobiology, learned regulation, reward prediction, and habit formation, click the link in the comments below and check out the full course inside The Academy.

Thread adapted from Dr Sanil Rege.

Skip the Carousel

1 2 3 4 5 6 7 8 9 10

1 day ago | [YT] | 11

The Academy by Psych Scene

“With this course, I now feel well equipped to address some of my patients' questions with greater confidence.”

Esketamine is not just another option in TRD.

It is a treatment pathway clinicians need to understand before it can be used safely.

The challenge is not simply whether it works or not.

It is knowing where it fits, who it fits, and how to use it safely in practice.

Led by Professor David Barton, our Intranasal Esketamine in the Management of Treatment-Resistant Depression course provides a clinically focused exploration of esketamine in TRD, including neurobiological mechanisms, practical administration, and long-term management.

In this course, you’ll learn how to:

- Understand the scope and burden of treatment-resistant depression

- Evaluate the evidence supporting intranasal esketamine in TRD

- Identify appropriate candidates, contraindications, and screening considerations

- Apply practical administration, monitoring, and side-effect management protocols

- Plan maintenance therapy, PBS funding, and relapse prevention strategies

Accreditation:
✅ 1.5 CPD hours
✅ Self-accreditable with RANZCP and other relevant organisations
✅ Self-accreditable with RACGP
✅ Certificate of completion

Start learning today. Click the link below:

2 days ago | [YT] | 4

The Academy by Psych Scene

Dissociation often appears as detachment and numbness.

Although these signs do not necessarily mean the system has switched off.

What appears as absence may actually be the opposite:

The brain doing ‘too much’.🧵👇

To learn more about the neuroscience of dissociation and its clinical implications in trauma disorders, click the link in the comments below and read the full article inside Psych Scene Hub.

Skip the Carousel

1 2 3 4 5 6 7 8 9 10

3 days ago | [YT] | 6

The Academy by Psych Scene

Generalised Anxiety Disorder often ‘hides’ in plain sight.

Not because the symptoms are invisible but because they can easily be mistaken for something entirely different. 🧵👇

To go deeper into Generalised Anxiety Disorder diagnosis and management, click the link in the comments below and read the full article inside Psych Scene Hub.

Skip the Carousel

1 2 3 4 5 6 7 8 9 10

4 days ago | [YT] | 9

The Academy by Psych Scene

BPD is not simply complex PTSD.

Yes, the two can overlap…

But they differ in 5 key clinical ways.

To go deeper into BPD diagnosis, trauma-informed formulation, and clinical management BPD, PTSD, and cPTSD, click the link in the comments below and explore the full course inside The Academy.

Skip the Carousel

1 2 3 4 5 6 7 8 9

5 days ago | [YT] | 11

The Academy by Psych Scene

Tricyclic Antidepressants (TCAs) are often treated as drugs psychiatry moved on from.

But in some patients, the very pharmacology that makes TCAs harder to prescribe may also be why they are worth considering.

TCAs are not outdated.

They are detail-dependent.

Their value comes from knowing when the pharmacology fits the patient, and when tolerability, cardiac risk, interactions, or overdose risk make another option more appropriate.

To go deeper into TCAs, MAOIs, mechanisms, safety considerations, and practical prescribing in psychiatry with Dr Ken Gillman explore the full course inside The Academy.

Link in the comments below.

Skip the Carousel

1 2 3 4 5 6 7 8 9 10

1 week ago | [YT] | 13

The Academy by Psych Scene

“Outstanding as always. Implementing what I’ve learned from this course has led to noticeable improvements in my patients. Truly an extremely valuable course.”

A diagnosis can be correct and still not tell you what to do next.

This is common across cases with complex presentations, competing differentials, and comorbidities that blur the clinical picture.

To bridge this gap, clinicians need an integrative formulation framework that connects phenomenology, neurobiology, and sociocultural context into a working model.

Led by Dr Sanil Rege, our Advanced Psychiatric Formulation and Strategic Management Series is a comprehensive, on-demand two-part series that builds structured, hypothesis-driven diagnostic formulation skills and then translates them into mechanism-informed management strategies for real-world clinical complexities.

In this course, you’ll learn how to:

- Build structured, hypothesis-driven formulations beyond DSM/ICD checklists

- Integrate phenomenological, neurobiological, psychodynamic, and sociocultural perspectives into one cohesive formulation

- Apply diagnostic hierarchies, functional domains, and the PACES™ framework to refine differentials and link symptoms to mechanisms

- Translate formulation into strategic management using a six-domain model, integrating medication strategy and evidence-based psychological approaches

Accreditation:
✅ 7.5 CPD hours (EA 7.5)
✅ Self-Accreditable with RANZCP
✅ Certificate of Completion

Start learning today. Link in the comments below.

1 week ago | [YT] | 3

The Academy by Psych Scene

“The course was highly engaging. It made it easier to keep up with new evidence in psychiatry and improved my confidence in day-to-day practice.”

Metabolic risk is one of the most persistent iatrogenic burdens of psychiatric care.

Clinicians can do everything right for symptom stabilisation and acute risk management.

Then metabolic dysfunction complicates engagement, recovery, and treatment adherence.

That’s where a structured framework for metabolic management in psychiatric practice matters.

Led by Professor Roger Chen, Metabolic Management in Psychiatry: The Role of GLP-1 and Emerging Agents is a clinically focused course designed to help clinicians recognise cardiometabolic risk in psychiatric care and apply practical prescribing, monitoring, and audit strategies, including the role of GLP-1 and GIP-based therapies.

In this course, you’ll learn how to:

- Identify how metabolic dysfunction can influence psychiatric outcomes and recovery

- Explain how GLP-1 receptor agonists work and recognise which patients may benefit

- Manage psychotropic weight gain, insulin resistance, and dysglycaemia through prescribing and monitoring

- Recognise emerging metabolic therapies relevant to mental health practice

- Apply the learning through case studies, quizzes, and clinical audit activities

Accreditation:
✅ 9 CPD hours (EA 3, RP 1, MO 5)
✅ Self-accreditable with RANZCP and other relevant organisations
✅ RACGP Accredited (GPs)
✅ Certificate of Completion

Start learning today. Link in the comments below.

2 weeks ago (edited) | [YT] | 3

The Academy by Psych Scene

Antidepressant tapering can look simple on paper:

halve the dose → halve it again → stop

But for some patients, the final reductions are where biology becomes less forgiving.

For them, the last milligrams matter more than they look.

To learn more about antidepressant mechanisms and deprescribing strategies, click the link in the comments below and check out the full course inside The Academy.

Skip the Carousel

1 2 3 4 5 6 7 8 9 10

2 weeks ago (edited) | [YT] | 10